As of November 15, 2009, confirmed speakers include:

• Robert Klein, Chairman – ICOC, California Institute for Regenerative Medicine
• Brock Reeve, Executive Director, Harvard Stem Cell Institute
• Geoff MacKay, CEO, Organogenesis
• John Walker, CEO, iPierian
• Lieutenant General Eric Schoomaker, M.D., Ph.D., The Surgeon General/Commander, U.S. Army Medical Command
• Anthony Atala, M.D., Director, Wake Forest Institute for Regenerative Medicine
• Alan Lewis, Ph.D., CEO, Juvenile Diabetes Research Foundation
• Andrew von Eschenbach, M.D., Senior Advisor, Greenleaf Health LLC; Senior Advisor, Center for Health Transformation
• Anthony Caggiano, M.D., Ph.D., Vice President, Preclinical Development, Acorda Therapeutics
• Dean Tozer, Senior Vice President, Advanced BioHealing
• Robert Lanza, M.D., Chief Scientific Officer, Advanced Cell Technology
• Ed Field, President and COO, Aldagen
• Lynnet Koh, CEO, America Stem Cell, Inc.
• Robert Deans, Ph.D., Senior Vice President, Regenerative Medicine, Athersys
• Ray Cypess, Ph.D., President, ATCC
• Gail Naughton, Ph.D., CEO, Histogen
• Joydeep Goswami, Ph.D., Vice President and General Manager, Primary and Stem Cell Systems, Life Technologies
• Vincent Ronfard, Ph.D., Vice President of Research, Organogenesis
• Lynn Allen-Hoffmann, Ph.D. CEO and CSO, Stratatech Corporation
• Tim Bertram, D.V.M., Ph.D., Senior Vice President, Science and Technology, Tengion
• Leslie Molony, CEO, Transgeneron
• Tim Coetzee, Ph.D., Executive Director, Fast Forward
• Jay Watkins, Managing Director, DeNovo Ventures
• Rick Blume, Managing Director, Excel Venture Management
• Garheng Kong, M.D., Ph.D., General Partner, InterSouth Partners
• Mostafa Analoui, Ph.D., Head of Healthcare and Life Science, The Livingston Group
• Sherrill Neff, Founding Partner, Quaker BioVentures
• Jeff Karan, General Partner, Proteus Ventures
• Gary Kurtzman, M.D., Vice President and Managing Director, Life Sciences Group, Safeguard Scientifics
• Steven Bauer, Ph.D., Chief, Cell and Tissue Therapy Branch, FDA Center for Biologics Evaluation and Research
• Bob Brady, Partner, Hogan & Hartson
• Michael Werner, Partner, Public Policy Group, Holland & Knight
• Bernie Siegel, Executive Director, Genetics Policy Institute
• Lee Buckler, Cell Therapy Group
• Michelle McMurry, M.D., Ph.D., Director, Health, Biomedical Science and Societal Initiative, The Aspen Institute
• Lesa Mitchell, Vice President, Kauffman Foundation
• Scott Weir, Pharm.D., Ph.D., University of Kansas, The Institute for Advancing Medical Innovation
• Sitta Sittampalam, Ph.D. University of Kansas, The Institute for Advancing Medical Innovation
• Camillo Ricordi, MD, Diabetes Research Institute, University of Miami Miller School of Medicine
• Mime Egani, Ph.D., Visiting Professor, Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University
• Professor Teuro Okano, Ph.D., Director of the Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University
• Buddy Ratner, Ph.D., Professor of Bioengineering and Chemical Engineering at the University of Washington and Director of UWEB (University of Washington Engineered Biomaterials), University of Washington
• Simon Cool, Ph.D., Institute of Medical Biology, A*STAR - Singapore
• Col. Jan Harris, MSN, Ph.D., U.S. Army Nurse Corps, Director, Congressionally Directed Medical Research Programs
• Col. Robert Vandre, DDS, US Army Medical Research and Materiel Command
• Morrie Ruffin, Managing Director, Adjuvant Global Advisors

Areas of Interest

Speakers represent the entire translational continuum from scientists to entrepreneurs to private equity funders to corporate business development executives, including those who influence health care, regulatory and reimbursement policy. The Translational Forum will feature the following industry groups and areas of interest:

• Corporate Venture
• Venture Capital
• Regenerative Medicine Ventures
• Pharmaceuticals
• Medical Devices
• Diagnostics
• Clinicians
• Disease Philanthropies
• U.S. Military
• Academic Research
• Healthcare Policy
• Regulators
• Reimbursement/Payers